serotonin antagonists

Preferred Label : serotonin antagonists;

MeSH definition : Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS.;

MeSH synonym : 5 hydroxytryptamine antagonists; antagonists, 5 ht; 5-ht antagonists; 5 ht antagonists; antagonists, 5 hydroxytryptamine; antiserotonergic agents; antagonists, serotonin; blockaders, serotonin; 5-hydroxytryptamine antagonists; antagonists, 5-ht; agents, antiserotonergic; serotonin blockaders; antagonists, 5-hydroxytryptamine; serotonin receptor blockers; blockers, serotonin receptor; receptor blockers, serotonin; serotonin receptor antagonists; antagonists, serotonin receptor; receptor antagonists, serotonin; 5-HT Antagonist; 5 HT Antagonist; Antagonist, 5-HT; 5-Hydroxytryptamine Antagonist; 5 Hydroxytryptamine Antagonist; Antagonist, 5-Hydroxytryptamine; Antiserotonergic Agent; Agent, Antiserotonergic; Serotonin Blockader; Blockader, Serotonin; Serotonin Receptor Antagonist; Antagonist, Serotonin Receptor; Receptor Antagonist, Serotonin; Serotonin Receptor Blocker; Blocker, Serotonin Receptor; Receptor Blocker, Serotonin; Serotonin Antagonist; Antagonist, Serotonin;

MeSH annotation : general or unspecified; prefer specifics; differentiate from SEROTONIN UPTAKE INHIBITORS: do not confuse with SEROTONIN AGONISTS;

Wikipedia link : https://en.wikipedia.org/wiki/Serotonin receptor antagonist;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D012702;

UMLS CUI

C0036753;

ATC code(s)
- serotonin antagonists [ATC Code]
- serotonin antagonists and diuretics [ATC Code]
- serotonin receptor antagonists [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Antagonist serotonin [ICHI extension code]
- Serotonin receptor antagonists [ICD-11 Extension code]
Currated CISMeF NLP mapping
- Antagonist serotonin [ICD-11 Extension code]
- Serotonin Antagonist [NCIt concept]
- serotonin antagonists [ATC Code]
- serotonin receptor antagonists [ATC Code]
Indexing information
- ((5,5-diphenyloxolan-2-yl)methyl)(2-phenoxyethyl)amine [MeSH Supplementary Concept]
- (2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine [MeSH Supplementary Concept]
- 3-(4-chlorophenyl)-1,4,5,6,7,8-hexahydro-1-(phenylmethyl)pyrazolo(3,4-d)azepine 2-hydroxy-1,2,3-propanetricarboxylate [MeSH Supplementary Concept]
- 5-((4-(2-methoxyphenyl)piperazin-1-yl)methyl)-2,2-diphenylcyclopentan-1-ol [MeSH Supplementary Concept]
- 8-(4-methylpiperazin-1-yl)-3-phenylsulfonylquinoline [MeSH Supplementary Concept]
- CGS 1068B [MeSH Supplementary Concept]
- CMP 42 [MeSH Supplementary Concept]
- CMP X compound [MeSH Supplementary Concept]
- CMP Y compound [MeSH Supplementary Concept]
- GR 65630 [MeSH Supplementary Concept]
- MDL 28727 [MeSH Supplementary Concept]
- SAM-531 [MeSH Supplementary Concept]
- iferanserin [MeSH Supplementary Concept]
MeSH Descriptor(s) used for indexing
- receptors, serotonin [MeSH Descriptor]
- serotonin [MeSH Descriptor]
Record concept(s)
- serotonin antagonists [MeSH concept]
See also
- Selective Serotonin Reuptake Inhibitors [MeSH Descriptor]
See also (suggested by CISMeF)
- receptors, serotonin [MeSH Descriptor]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- (2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine [MeSH Supplementary Concept]
- 1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate [MeSH Supplementary Concept]
- 1-(2-methoxyphenyl)-4-(4-(2-phthalimido)butyl)piperazine [MeSH Supplementary Concept]
- 1-(2-methoxyphenyl)-4-(4--(2-phthalimido)cyclohexyl)piperazine [MeSH Supplementary Concept]
- 1-(4-fluorophenyl)-2-(4-(phenylsulfonyl)-1-piperidinyl)ethanone [MeSH Supplementary Concept]
- 2-((2-(dimethylamino)ethyl)thio)-3-phenylquinoline [MeSH Supplementary Concept]
- 2-(3,5-dimethylpiperidino)ethyl 4-amino-5-chloro-2-methoxybenzoate [MeSH Supplementary Concept]
- 2-(4-((6-amino-1,3-dioxo-1H-benzo(de)isoquinolin-2(3H)-yl)methyl)piperidin-1-yl)ethyl 4-amino-5-chloro-2-methoxybenzoate [MeSH Supplementary Concept]
- 2-amino-4-(4-fluoronaphth-1-yl)-6-isopropylpyrimidine [MeSH Supplementary Concept]
- 2-ethyl-5-methoxy-N,N-dimethyltryptamine [MeSH Supplementary Concept]
- 2-methoxy-4-amino-5-chlorobenzoic acid 2-(diethylamino)ethyl ester [MeSH Supplementary Concept]
- 2a-(4-phenyl-1,2,3,6-tetrahydropyridyl)cyclohex(a-3,4)indole-2-one [MeSH Supplementary Concept]
- 3,N-dimethyl-N-(1-methyl-3-(4-methylpiperidin-1-yl)propyl)benzenesulfonamide [MeSH Supplementary Concept]
- 3-(3-(dimethylamino)propyl)-4-hydroxy-N-(4-(4-pyridinyl)phenyl)benzamide [MeSH Supplementary Concept]
- 3-(benzenesulfonyl)-2-(methylsulfanyl)pyrido(1,2-a)pyrimidin-4-ylidenamine [MeSH Supplementary Concept]
- 4-((1-(2-(2,4-difluorophenyl)ethyl)-4-piperidinyl)sulfonyl)benzamide [MeSH Supplementary Concept]
- 4-((1-(2-(2,4-difluorophenyl)ethyl)-4-piperidinyl)sulfonyl)benzonitrile [MeSH Supplementary Concept]
- 4-(2'-methoxyphenyl)-1-(2'-(N-(2''-pyridinyl)-4-iodobenzamido)ethyl)piperazine [MeSH Supplementary Concept]
- 4-(3-(1-benzotriazolyl)cyclohexyl)-1-(2-methoxyphenyl)piperazine [MeSH Supplementary Concept]
- 5-((N-propylpiperidin-4-yl)methoxy)-1,2,3,4-tetrahydrobenzo(h)(1,6)naphthyridine [MeSH Supplementary Concept]
- 5-(4-fluorophenyl)-3-(2-hydroxy-3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)-5-methylhydantoin [MeSH Supplementary Concept]
- 6-nitroquipazine [MeSH Supplementary Concept]
- 8-(5-(5-amino-2,4-dimethoxyphenyl)-5-oxopentyl)-1,3,8-triazaspiro(4.5)decane-2,4-dione [MeSH Supplementary Concept]
- AVN-492 [MeSH Supplementary Concept]
- DuP 734 [MeSH Supplementary Concept]
- EEDQ [MeSH Supplementary Concept]
- GR 113808 [MeSH Supplementary Concept]
- GR 127935 [MeSH Supplementary Concept]
- LY 367265 [MeSH Supplementary Concept]
- LY 393558 [MeSH Supplementary Concept]
- LY 426965 [MeSH Supplementary Concept]
- LY 53857 [MeSH Supplementary Concept]
- McN 5652 [MeSH Supplementary Concept]
- N,N-Dimethyltryptamine [MeSH Descriptor]
- N-(1-azabicyclo(2.2.2)oct-3-yl)--6-chlorobenzimidazole-4-carboxamide [MeSH Supplementary Concept]
- N-(1-azabicyclo(2.2.2)oct-3-yl)-6--chloro-7-nitrobenzimidazole-4-carboxamide [MeSH Supplementary Concept]
- N-(1-azabicyclo(2.2.2)oct-3-yl)benzimidazole-4-carboxamide [MeSH Supplementary Concept]
- N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide [MeSH Supplementary Concept]
- N-(5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl)-4-morpholinobenzamide [MeSH Supplementary Concept]
- REC 15-3079 [MeSH Supplementary Concept]
- SB 204070A [MeSH Supplementary Concept]
- SB 206553 [MeSH Supplementary Concept]
- SL 88.0338 [MeSH Supplementary Concept]
- SR 46349B [MeSH Supplementary Concept]
- UH 301 [MeSH Supplementary Concept]
- WAY 100135 [MeSH Supplementary Concept]
- alosetron [MeSH Supplementary Concept]
- altanserin [MeSH Supplementary Concept]
- amperozide [MeSH Supplementary Concept]
- azasetron [MeSH Supplementary Concept]
- bemesetron [MeSH Supplementary Concept]
- binospirone mesylate [MeSH Supplementary Concept]
- bufotenin [MeSH Descriptor]
- butanserin [MeSH Supplementary Concept]
- cianopramine [MeSH Supplementary Concept]
- cinanserin [MeSH Descriptor]
- clovoxamine [MeSH Supplementary Concept]
- clozapine [MeSH Descriptor]
- cyanopindolol [MeSH Supplementary Concept]
- cyproheptadine [MeSH Descriptor]
- deramciclane [MeSH Supplementary Concept]
- dotarizine [MeSH Supplementary Concept]
- fananserin [MeSH Supplementary Concept]
- fenclonine [MeSH Descriptor]
- iprazochrome [MeSH Supplementary Concept]
- ketanserin [MeSH Descriptor]
- lysergic acid diethylamide [MeSH Descriptor]
- mesulergine [MeSH Supplementary Concept]
- metergoline [MeSH Descriptor]
- methiothepin [MeSH Descriptor]
- methysergide [MeSH Descriptor]
- mianserin [MeSH Descriptor]
- nafronyl [MeSH Descriptor]
- pindolol [MeSH Descriptor]
- pipamperone [MeSH Supplementary Concept]
- pizotyline [MeSH Descriptor]
- ramosetron [MeSH Supplementary Concept]
- renzapride [MeSH Supplementary Concept]
- risperidone [MeSH Descriptor]
- ritanserin [MeSH Descriptor]
- sarpogrelate [MeSH Supplementary Concept]
- setoperone [MeSH Supplementary Concept]
- tolfenamic acid [MeSH Supplementary Concept]
- volinanserin [MeSH Supplementary Concept]
- xylamidine [MeSH Supplementary Concept]
- zacopride [MeSH Supplementary Concept]
- zatosetron [MeSH Supplementary Concept]
- ziprasidone [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Antagonist serotonin [ICD-11 Extension code]
- Serotonin Antagonist [NCIt concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients